Journals by field · Health Sciences · Medicine

Journals in Genetics

36 established journals that publish mainly in Genetics, compared by fees, open access and citation rates, updated 2026-10-14.

Which fit your paper?See all 36 journals

36 established journals publish at least 20 % of their articles in Genetics. 20 of them are fully open access. Where open-access journals charge a fee, the median is 2 500 USD. Highest recent citation rates: Stem Cell Research & Therapy, Regenerative Therapy, Stem Cells Translational Medicine.

36 journals

Most relevant first: how much of a journal's work is in Genetics, how many articles it publishes and how often they are cited. Click a column to sort.

Stem Cell Research & TherapyBioMed Central35 %5597.591763 190 USD
Neuro-OncologyOxford University Press44 %2 5231.20216Subscription; open access option 5 132 USD
Journal of Neuro-OncologySpringer Science+Business Media38 %3453.14166Subscription; open access option 4 590 USD
Stem Cells Translational MedicineWiley29 %1344.671302 963 USD
Stem Cell Reviews and ReportsSpringer Nature27 %1894.44110Subscription; open access option 4 390 USD
World Journal of Stem CellsBaishideng Publishing Group33 %993.4775Subscription
Neuro-Oncology AdvancesOxford University Press36 %5551.16502 615 USD
Stem Cells InternationalHindawi Publishing Corporation32 %1522.241242 570 USD
Regenerative TherapyElsevier BV20 %1525.31481 800 USD
Neuro-Oncology PracticeOxford University Press32 %1021.7845Subscription; open access option 5 036 USD
International Journal of Stem CellsPublisher unknown31 %383.6644Open access, fee unknown
Stem CellsOxford University Press22 %1103.88286Subscription; open access option 4 477 USD
Current Stem Cell Research & TherapyBentham Science Publishers30 %971.5371Subscription
Stem Cells and DevelopmentMary Ann Liebert, Inc.26 %682.50152Subscription
Thalassemia ReportsPAGEPress (Italy)40 %142.57141 207 USD
Journal of Neuromuscular DiseasesIOS Press21 %1033.1657Subscription
CNS OncologyFuture Medicine38 %123.38421 415 USD
CytotherapyElsevier BV22 %7271.13126Subscription; open access option 3 300 USD
HemoglobinTaylor & Francis35 %660.7959Subscription
Brain Tumor PathologySpringer Science+Business Media32 %271.3155Subscription; open access option 4 290 USD
Brain Tumor Research and TreatmentPublisher unknown25 %322.0929Subscription
Frontiers in HematologyFrontiers Media21 %322.15112 353 USD
Journal of sickle cell disease.Association of College and Research Libraries51 %310.3342 500 USD
American Journal of Stem CellsPublisher unknown25 %83.417Subscription
Stem Cells and Cloning Advances and ApplicationsDove Medical Press32 %81.27322 320 USD
Journal of Stem Cells and Regenerative MedicineGN Corporation Limited29 %130.7324380 USD
Clinical NeuropathologyDustri-Verlag21 %340.7441Subscription
Blood Red Cells & IronElsevier BV27 %90.5643 000 USD
Journal Of Stem Cell ResearchPublisher unknown28 %140.294Subscription
Blood Global HematologyElsevier BV20 %120.4933 000 USD
Journal of Stem Cell Therapy and TransplantationHeighten Science Publications24 %60.337Open access, fee unknown
International Journal of Translational SciencePublisher unknown25 %50.343Open access, fee unknown
Journal of Stem Cell Research & TherapeuticsMedCrave Group25 %120.198Open access, fee unknown
Stem Cells Research Development & TherapyPublisher unknown27 %120.117Open access, fee unknown
Journal of Stem Cell Research and Tissue EngineeringAirlangga University23 %100.043Open access, fee unknown
Stem Cell & Regenerative MedicinePublisher unknown31 %80.0010Open access, fee unknown

Which of these fit your paper?

Paste your title and abstract and get these journals ranked for your work, with the closest published articles as evidence. Free, and your abstract is never stored.

Free, 3 a day without an account. Never stored.

Journals in CWTS Journal Indicators Core or the Directory of Open Access Journals that published at least 20 articles in the last five years, mostly in English. "In this field" is the share of a journal's articles that OpenAlex classifies in Genetics. Citation rate is OpenAlex's two-year mean citedness, an open measure similar to the journal impact factor. Fees are taken from OpenAlex and DOAJ and can be out of date: always check the journal's own website before you submit.